Mandatory notification of trade
Gentian Diagnostics ASA (GENT) · publisert 2022-08-26 11:17 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass | Tolket via |
|---|---|---|---|---|---|---|---|---|
| Tomas Kramar | Board Member | acquisition | 2 166 | 44,53 NOK | 2022-08-26 | NO0010748866 | XOSL – Oslo Børs | rules |
Vedlegg
- Notification_Kramar 08 2022.pdf (tekst hentet ut)
Meldingstekst
Moss, 26 August 2022
Gentian Diagnostics ASA has today been notified that the following transaction has been completed by a primary insider in Gentian Diagnostics ASA: Tomas Kramar, board member and primary insider in Gentian Diagnostics ASA, has today bought 2,166 shares at an average price of NOK 44.53 per share. After the transaction, Tomas Kramar holds 5,802 shares in Gentian Diagnostics ASA.
Please refer to the attached notification of trading for further details.
This information is subject to the disclosure requirements in the EU Market Abuse Regulation and section 5-12 of the Norwegian Securities Trading Act.
For further information, please contact: Njaal Kind, Group CFO, njaal.kind@gentian.no, +47 91 90 65 25